Top Markets
Coin of the day
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR
Rank in Stocks #18069
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating... Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Share Price
$3.54
Last synced: 2026-09-02
Market Cap
$213.59M
Change (1 day)
3.06%
Change (1 year)
-3.94%
Country
US
Trade Voyager Therapeutics, Inc. (VYGR)

Category

Stock price history for Voyager Therapeutics, Inc. (VYGR)
Highest end of day price: $3.48 on 2026-09-01

Lowest end of day price: $21.80 on 2015-11-01
Stock price history of Voyager Therapeutics, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -5.39%
2025 -31.67%
2024 -23.54%
2023 35.12%
2022 105.49%
2021 -64.56%
2020 -41.72%
2019 39.09%
2018 -32.12%
2017 8.56%
2016 -42.81%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.68 -9.23%
AU
$757.71 6.76%
CH